Therapeutic Potential of Rare Sesterterpenoids from Aspergillus Variecolor Strain SDG and Docking Studies
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202401951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Koochana Pranay Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products and Medicinal Chemistry, CSIR- Indian Institute of Chemical Technology, Hyderabad, 500607, India. Hauptthemen laut MEDLINE: Aspergillus, Molecular Docking Simulation, Antineoplastic Agents, alpha-Glucosidases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Council of Scientific & Industrial Research.
Abstract (Originalsprache)
Ethyl acetate extract of the cultures of the soil‐derived filamentous fungus, Aspergillus variecolor SDG strain from Nallamala forest resulted in the isolation of extremely rare sesterterpenoids, stellatic acid ( 1 ) and andilesin C ( 2 ). We report a thorough chemical characterization of these compounds using various spectroscopic techniques and evaluation of their in vitro preclinical therapeutic potential. Stellatic acid exhibits potent antioxidant activity with an IC 50 of 38 μg/mL and significant anticancer activity against HeLa, HepG2, MCF7, and A549 cancer cell lines with an IC 50 of 7–12 μM. On the other hand, andilesin C displayed moderate cytotoxicity against DU145 and B16F10 cancer cell lines but lacked antioxidant activity. Furthermore, the potential hypoglycemic property of stellatic acid was evaluated by measuring its inhibitory effect against α‐glucosidase. It exhibited tenfold potency against yeast α‐glucosidase (IC 50 101.73 μg/mL) than mammalian α‐glucosidase (IC 50 1000.00 μg/mL). Docking studies were also performed to suggest the interaction mode of stellatic acid in the α‐glucosidase enzyme active site. Notably, yeast α‐glucosidase shows a higher affinity towards stellatic acid than mammalian α‐glucosidase (3TOP). Thus, the in vitro preclinical study of stellatic acid suggests its potential efficacy in therapeutic drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Products and Medicinal Chemistry, CSIR- Indian Institute of Chemical Technology, Hyderabad, 500607, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Applied Biology Division, CSIR- Indian Institute of Chemical Technology, Hyderabad, 500607, India.
ORCID-Profile: Umme Ummarah Fariha, Ponnapalli Mangala Gowri
Förderung
- Council of Scientific & Industrial Research
Zitieren
APA
Kumar, K. P., Rao, A. S. C. V. A., Sunkara, K., Fariha, U. U., Rajeswari, B. U., Misra, S., & Gowri, P. M. (2025). Therapeutic Potential of Rare Sesterterpenoids from Aspergillus Variecolor Strain SDG and Docking Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401951
Vancouver
Kumar KP, Rao ASCVA, Sunkara K, Fariha UU, Rajeswari BU, Misra S, et al. Therapeutic Potential of Rare Sesterterpenoids from Aspergillus Variecolor Strain SDG and Docking Studies. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401951
BibTeX
@article{Kumar2025,
author = {Kumar, Koochana Pranay and Rao, Annam S Ch V Appa and Sunkara, Kavya and Fariha, Umme Ummarah and Rajeswari, Batchu Uma and Misra, Sunil and Gowri, Ponnapalli Mangala},
title = {Therapeutic Potential of Rare Sesterterpenoids from Aspergillus Variecolor Strain SDG and Docking Studies},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202401951}
}
EUVIMED